Energetic efficiency of infant formulae: a review by Fleddermann, Manja et al.
E-Mail karger@karger.com
 Ann Nutr Metab 2014;64:276–283 
 DOI: 10.1159/000365034 
 Energetic Efficiency of Infant Formulae: 
A Review 
 Manja Fleddermann    Hans Demmelmair    Berthold Koletzko  
 Dr. von Hauner Children’s Hospital, University of Munich Medical Center,  Munich , Germany
 
efficiency by 11%. The quality of formula protein, specifically 
an increased whey-to-casein ratio, an increased α-lactalbu-
min content, or a higher tryptophan content increased the 
energetic efficiency by about 13%. We conclude that fat ab-
sorption and protein quality have the potential to modulate 
energetic efficiency and may contribute to the observed dif-
ferences in growth and metabolism between breast-fed and 
formula-fed infants.  © 2014 S. Karger AG, Basel 
 Introduction 
 Compared to breast-fed (BF) infants, the energy re-
quirements of formula-fed (FF) infants are about 15% 
higher at the age of 1 month and about 7% higher at the 
age of 6 months  [1] . Observational data indicate that 
energetic efficiency (EE; growth-weight gain or length 
gain per 100 kcal) is 11% higher in BF infants than in FF 
infants  [2, 3] . Limited data is available on the relation-
ship between the composition of infant formulae and 
their corresponding EE for growth. However, FF infants 
consume up to 26% more energy and show higher mean 
weight gains than BF infants  [3] . This higher early 
weight gain velocity has been associated with an in-
creased risk of obesity and type 2 diabetes in later life 
 [4–8] . 
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 Abstract 
 Breast-fed and formula-fed infants differ in terms of nutrient 
intake, growth, and metabolic and endocrine responses. The 
energetic efficiency, i.e. the weight or length gain per 100 
kcal of energy intake, of breast-fed infants is about 11% high-
er than the energetic efficiency of formula-fed infants. Only 
limited data is available on the influence of formula composi-
tion on the energetic efficiency of infant formulae. We con-
ducted a review of controlled trials to identify the impact of 
the macronutrient composition of infant formulae on ener-
getic efficiency. An electronic literature search was conduct-
ed in February 2014. Intervention trials that investigated the 
effect of an infant formula with a modified macronutrient 
composition and reported the weight, length, and nutrition-
al intake of apparently healthy, term, fully formula-fed infants 
with a normal weight were included. Thirteen trials met the 
inclusion criteria. The results showed no effect of the total 
content of energy, carbohydrate, protein, or fat on energetic 
efficiency. In contrast, small increasing effects of higher gly-
cemic carbohydrates on energetic efficiency were identified. 
Improved fat absorption via the use of palmitic acid at the 
sn-2 ester position of triacylglycerol increased the energetic 
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 We observed differences in EE in a study on 213 
healthy term infants who were randomized to either a 
reduced-protein infant formula with a higher α-lactal-
bumin (ALAB) content and added long-chain polyunsat-
urated fatty acids (LC-PUFA) or a control formula (CF) 
with a standard protein content without LC-PUFA until 
the age of 120 days  [9] . The mean daily weight gain was 
tendentially higher at 30.2 g in the reduced-protein group 
than in the control group (28.3 g). Infants in the reduced-
protein group consumed significantly less energy during 
the study period (490 vs. 531 kcal/day). Thus, the EE for 
weight was about 12% higher in infants who received the 
reduced-protein formula with ALAB and LC-PUFA, 
which we considered to be induced by different dietary 
protein and amino acid compositions  [9] . 
 This finding prompted us to review the available data 
on the effects of macronutrients of infant formulae on EE 
in fully FF infants during the first months of life. We 
aimed to identify the relationship of infant formula com-
position with EE for growth and searched for effects of 
macronutrient contents and of modified protein, fat, and 
carbohydrate sources.
 Methods 
 A structured electronic literature search was carried out on Feb-
ruary 7, 2014, on PubMed.gov. The search term was: [infant formu-
la] not [preterm or premature] and [Clinical Trial] and [humans]. 
The studies included in the review met the following criteria: (1) the 
effect of an infant formula was investigated, (2) weight and length 
and energy intake were evaluated, (3) an FF control group was in-
cluded, and (4) participants were apparently healthy infants born at 
term ( ≥ 37 weeks of gestation) with a normal weight (>2,500 g at birth 
or a weight above the 5th percentile of WHO growth charts) and were 
fully FF (contribution of other foods was <25% of the energy intake).
 Full-text articles which met these inclusion criteria were extracted 
into an EndNote database (EndNote X5; Thomson Reuters, Philadel-
phia, Pa., USA). Information on methods, populations, interven-
tions, growth, and nutritional intakes was collected. If the mean 
weight, length gain, and dietary intake were not reported in grams/
day, millimeters/day, and kilocalories/day, respectively, they were 
calculated using reported data. If the growth or dietary intake could 
not be calculated from reported data, the study was excluded from 
analysis. Additionally, the study of Fleddermann et al.  [9] was con-
sidered in the analysis and used as an additional reference. 
 Growth and energy intakes were compared between interven-
tion and control groups for all included studies. When the dietary 
intake was reported in kilocalories/kilogram of body weight, the 
mean dietary energy intake was calculated using the absolute 
weight at assessment of the dietary intake. Based on Fleddermann 
et al.  [9] , the EE was calculated as the ratio of weight or length gain 
(expressed as g/day or mm/day) and the average energy intake per 
day during a study. EE was expressed as grams/100 kilocalories for 
weight or as millimeters/100 kilocalories for length.
 Results 
 Selection of Eligible Papers 
 The literature search yielded 808 references. Of those 
808 studies, 620 were excluded on the basis of titles and 
abstracts not fulfilling our inclusion criteria, while 188 
were identified as potentially eligible ( fig. 1 ). In total, 94 
studies with a focus on the macronutrient composition of 
infant formulae were obtained as full-text articles. After a 
detailed evaluation, 13 studies of different population 
groups met the inclusion criteria and were included in the 
analysis. The main reason for exclusion was inadequate 
reporting of the energy intake or growth.
 Baseline Characteristics and Results of the Included 
Trials 
 The key characteristics of the included trials are pre-
sented in  table 1 . All studies assessed growth and energy 
intake from birth or the first month of life until the ages 
of 3–6 months. All but 2 studies included infants of both 
sexes, while Fomon et al.  [10] and Carnielli et al.  [11] en-
rolled male infants only. Ten of 14 studies aimed to inves-
tigate the suitability and safety of the formulae with a fo-
cus on protein and carbohydrate contents  [2, 10, 12–19] , 
while studies focused on fat composition aimed to inves-
tigate fat or mineral balances  [11, 20, 21] . Schmelzle et al. 
 [17] and Lasekan et al.  [19] studied modified carbohy-
drate components in formulae. The studies of Koo et al. 
 [20] , Kennedy et al.  [21] , and Carnielli et al.  [11] investi-
gated formulae with modified fat contents. Most of the 
included studies focused on the protein component  [2, 
10, 12–17] . 
 In total, the studies evaluated data of 1,561 partici-
pants. The duration of the interventions varied from 35 
days to 6 months. Further details on the population char-
acteristics, compositions of formulae, and available data 
of the included studies are shown in  table 1 .
 Growth and Energy Intake 
 The observed weight gains were 22.5–35.9 g/day, and 
length gains varied from 0.87 to 1.59 mm/day ( table 2 ). 
The anthropometric gains differed between the different 
study populations and tended to be higher in smaller in-
fants. The highest anthropometric gains (31.7–35.9 g/day 
or 1.27–1.29 mm/day) were observed in infants who were 
8–12 weeks old at the study end, compared to lower gains 
in infants aged 6 months at the study end (22.5–24.4 g/
day or 0.87–0.99 mm/day).
 The energy intake for study formulae varied between 
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Reference Population characteristics IF 1 IF 2 CF Age Outcomes
Fleddermann 
et al. [9]
Apparently healthy term 
singletons, 37 – 41 weeks 
of gestation, birth weight 
between the 3rd and 97th 
percentiles of Euro growth 
charts, n = 107 (IF), n = 
106 (CF)
67 kcal, 1.3 g protein 
(higher ALAB content, free 
Trp and phenylalanine), 




67 kcal, 1.5 g protein, 









Fomon et al. 
[10]
Male term infants, birth 
weight >2,500 g, n = 13 
(CF), n = 15 (IF)
67 kcal, 0.8 g protein, 3.75 g
fat, 7.58 g carbohydrates
67 kcal, 1.14 g protein, 









Turck et al. 
[12]
Healthy term newborns, 
37 – 42 weeks of gestation, 
birth weight 2,500 – 
4,200 g, n = 51 (IF), 
n = 50 (CF)
67 kcal, 1.2 g protein (30% 




67 kcal, 1.7 g protein 
(70% casein/30% whey), 
7.8 g carbohydrates 
(70% lactose/30% 








Rozé et al. 
[13]
>37 weeks of gestation, 
without human milk 
before inclusion, n = 43 
(IF), n = 45 (CF)
68 kcal, 1.4 g protein (0.3 g 
ALAB, 60% whey/40% 
casein), 7.6 g carbohydrates, 
3.5 g fat (12.6 mg 
arachidonic acid, 7 mg 
docosahexaenoic acid) plus 
different symbiotics
72 kcal, 1.5 g protein 
(50% whey/50% casein), 
8.9 g carbohydrates, 
3.4 g fat (no arachidonic 






baseline and 6 
months), energy 
intake (kcal/day)
Davis et al. 
[14]
Healthy term infants, 
weight-for-length at birth 
(10th to 90th percentiles 
of the Centers for Disease 
Control and Prevention), 
n = 64 for each group
67 kcal, 1.4 g protein 
(0.22 g ALAB), 7.3 g 
carbohydrates, 3.6 g fat
67 kcal, 1.5 g protein 
(0.13 g ALAB), 









 Table 1.  Summary of the main characteristics and main results of the included trials
Potentially relevant references
identified (n = 808)
References excluded because of:
   Illness/high risk/small for gestational age (n = 298)
   Outcome not within the first year (n = 35)
   No focus on composition of formula (n = 288) 
References excluded because of:
   Duplication (n = 1)
   Short intervention period (n = 1)
   High intake of other foods (n = 4)
   Inadequate reporting of intake/
        growth (n = 74)
References screened (n = 188)
Suitable references –
macronutrients (n = 13) 


















Macronutrients (n = 94)
 Fig. 1. Articles identified, screened, as-





















   
   
   
   
   
   
   
   
   
   
   

























Reference Population characteristics IF 1 IF 2 CF Age Outcomes
Räihä et al. 
[15]
Healthy newborns, 37 – 42 
weeks of gestation, birth 
weight 2,501 – 4,500 g, n = 
29 (IF), n = 27 (IF 2), n = 
29 (CF)
66.3 kcal, 1.26 g protein 
(modified sweet whey, 
70% whey/30% casein), 
higher lactose content


















no infants with atopic 
disease, n = 25 (IF), 
n = 20 (CF)
67 kcal, 1.5 g protein (100% 
whey protein hydrolysate), 
6.9 g carbohydrates (38% 
lactose/62% maltose plus 
glucose polymers), 3.6 g fat
66 kcal, 1.4 g protein 
(60% whey/40% casein), 
7.1 g carbohydrates 










>37 weeks of gestation, 
appropriate weight for 
gestational age, n = 73 
(IF), n = 76 (CF)
73.3 kcal, 1.33 g protein 
(40% whey/60% casein, 
plus Trp), unknown 
carbohydrate and fat 
contents
66.9 kcal, 1.59 g protein 
(60% whey/40% casein, 
no extra Trp), unknown 
carbohydrate and fat 
contents








et al. [17] 
Gestational age 37 – 42 
weeks, birth weight 
(10th to 90th percentiles), 
singleton healthy babies, 
mothers without 
significant illness or 
disabilities, n = 49 (IF), 
n = 52 (CF)
70 kcal, 1.7 g protein 
(100% hydrolyzed 




3.3 g fat, 0.8 g prebiotics
 67 kcal, 1.5 g protein 
(60% whey/40% casein), 
7.2 g carbohydrates 
(100% lactose), 3.6 g fat, 
no prebiotics 







Heubi et al. 
[18]
Healthy term infants, 
gestational age 38 – 42 
weeks, n = 70 (IF), n = 67 
(CF)
67.2 kcal, 1.5 g protein, 
7.2 g carbohydrates (75% 
maltodextrin/25% sucrose), 
3.6 g fat
67.2 kcal, 1.5 g protein, 
7.2 g carbohydrates 













weeks 37 – 42, weight 
(5th and 95th percentiles 
of the National Center for 
Health Statistics), n = 63 
(IF), n = 65 (CF)
67.6 kcal, 1.4 g protein, 7.23 
g carbohydrates 
(55% corn syrup/45% 
sucrose), 3.65 g fat
67.6 kcal, 1.4 g protein, 
7.23 g carbohydrates 







Koo et al. 
[20]
Healthy singletons, 
<2 weeks, gestational age 
37 – 42 weeks, n = 63 (IF), 
n = 65 (CF)
67.6 kcal, 1.42 g protein 
(nonfat milk protein, 
reduced mineral whey), 
7.37 g carbohydrates, 
3.58 g fat (45% palm/palm 
olein)
67.6 kcal, 1.4 g protein 
(nonfat milk protein, 
whey protein 
concentrate), 7.3 g 
carbohydrates, 3.65 g fat 
(without palm olein)







et al. [21] 
≥37 weeks of gestation, 
birth weight >5th 
percentile, n = 100 (IF), 
n = 103 (CF)
73 kcal, 1.6 g protein, 
7.1 g carbohydrates, 
4.2 g fat (50% palmitate at 
the sn-2 position)
70 kcal, 1.6 g protein, 
7.1 g carbohydrates, 
3.9 g fat (12% palmitate 
at the sn-2 position)










Healthy term males, free 
of manifest disease, n = 9 
for each group
66 kcal, 1.4 g protein, 
3.6 g fat (23.9% palmitic 
acid, 66% of which 
esterified to the sn-2 
position), unknown 
carbohydrates
66 kcal, 1.4 g 
protein, 3.6 g fat 
(24% palmitic 
acid, 39% of which 




66 kcal, 1.4 g protein, 
3.6 g fat (19.9% palmitic 
acids, 13% of which 






(absolute at birth 
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for the new established and modified intervention formu-
lae (IF) was lower (up to 63 kcal/day) than or similar 
(maximum 13 kcal/day higher in 3 studies) to the energy 
intake provided by CF.
 Calculated EE 
 The EE for growth was calculated for all studies and 
ranged from 3.43 to 7.26 g/100 kcal for weight gain
and from 0.14 to 0.37 mm/100 kcal for length gain ( ta-
ble 2 ). The largest difference in EE between the inter-
vention and control groups of one study (EE of IF mi-
nus EE of CF) was observed in 6 of 9 protein-focused 
studies  [2, 9, 13, 14, 16, 17] and in 1 study on fat modi-
fication  [11] . 
 There were no consistent effects of the total contents 
of energy, protein, carbohydrates, or fat on EE. Regard-
ing protein quality, Davis et al.  [14] , Fleddermann et al. 
 [9] , and Rozé et al.  [13] observed an about 10–12% high-
er EE for weight with ALAB-enriched formulae. A high-
er whey-to-casein ratio  [12, 13, 15, 17, 20] as well as a 
 Table 2.  Summary of growth, energy intake, and calculated EE















Fleddermann et al. [9] IF 30.2 1.06 490 6.45 0.22
CF 28.3 0.99 531 5.67 0.19
Fomon et al. [10] IF 29.3 1.04 577 5.08 0.18
CF 31.3 1.10 604 5.19 0.18
Turck et al. [12] IF 29.7 1.12 477 6.22 0.23
CF 29.3 1.15 506 5.79 0.23
Rozé et al. [13] IF 24.7 0.89 449 5.51 0.20
CF 22.5 0.87 460 4.90 0.19
Davis et al. [14] IF 35.9 1.29 661 5.43 0.20
CF 35.0 1.31 718 4.87 0.18
Räihä et al. [15] IF 28.1 0.96 520 5.40 0.18
IF 2 25.1 0.95 504 4.97 0.19
CF 27.8 1.04 565 4.92 0.18
Vandenplas et al. [16] IF 27.2 1.18 395 6.88 0.30
CF 27.2 1.14 449 6.06 0.25
Hanning et al. [2] IF 31.7 1.23 520 6.09 0.24
CF 30.6 1.27 583 5.25 0.22
Schmelzle et al. [17] IF 35.6 1.30 490 7.26 0.27
CF 32.7 1.20 510 6.41 0.24
Heubi et al. [18] IF 33.6 1.18 528 6.37 0.22
CF 32.7 1.21 525 6.23 0.23
Lasekan et al. [19] IF 31.1 1.15 508 6.12 0.23
CF 29.4 1.15 496 5.93 0.23
Koo et al. [20] IF 24.4 0.97 711 3.43 0.14
CF 25.5 0.99 698 3.65 0.14
Kennedy et al. [21] IF 33.2 1.27 526 6.31 0.25
CF 33.2 1.32 540 6.15 0.24
Carnielli et al. [11] IF 29.2 1.29 417 7.01 0.31
IF 2 23.3 1.26 416 5.58 0.30
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higher tryptophan (Trp) content  [2, 9] also enhanced 
the EE. Modifications of the carbohydrate sources of in-
fant formulae resulted in only modest increases in EE of 
2–3% when combinations of maltodextrin, sucrose, or 
corn syrup and lactose were compared to lactose-only 
formulae  [17–19] . Studies on modification of the fat 
source, with use of a structured triacylglycerol with pref-
erential esterification of palmitic acid at the sn-2 posi-
tion, reported an increased EE of 4–11% with a high pal-
mitic acid content at the sn-2 position of triacylglycerols 
 [11, 21] .
 Discussion 
 This review documents the effects of infant formula 
composition on EE. Intervention trials on infants from 
birth to 6 months of age were conducted on 1,561 infants. 
The results showed no effect of total contents of energy, 
protein, carbohydrates, or fat on EE, but did show effects 
of macronutrient quality or source.
 The results on modification of the carbohydrate 
source showed no or only a slight impact on EE of 2–
4%. This small increase might be related to carbohy-
drates with a higher glycemic index, such as maltodex-
trin (glycemic index 80–105), corn syrup (glycemic in-
dex 115), sucrose (glycemic index 65), and starch (gly-
cemic index 100), as compared to lactose (glycemic 
index 46), which may result in elevated blood glucose 
and insulin levels  [22] . We have proposed that elevated 
insulin levels may induce enhanced infant weight gain 
and fat deposition and an increased later risk of adipos-
ity and obesity  [23] .
 The effect of palmitic acid positioning in the dietary 
triacylglycerol was investigated in studies on fat modifi-
cation  [11, 20, 21] . Palmitic acid is the most abundant 
saturated fatty acid in human milk triacylglycerols  [24] . 
Use of a structured triacylglycerol with preferential es-
terification of palmitic acid at the sn-2 ester position in-
stead of the sn-1,3 position increased the EE for weight 
by about 11% and that for length by about 16%  [11] . The 
sn-2 ester bond is not cleaved during the digestion by 
pancreatic lipase, and the resulting sn-2 palmitoyl 
monoacylglycerol is more efficiently absorbed than free 
palmitic acid  [11] , which increases the metabolizable 
energy. 
 The major factor influencing EE that we identified is 
protein quality. Improved protein quality of formulae 
may result in a lower total energy intake via formula  [9, 
12–15] with a sufficient supply of bioavailable essential 
amino acids. In infant formula, Trp becomes the first 
limiting amino acid when the protein content is reduced 
and no free amino acids are added  [25] . An adequate 
supply of Trp can be achieved via the addition of free 
Trp or an increase in ALAB content. As the predomi-
nant whey fraction in human milk, ALAB is the main 
Trp source in BF infants, and its incorporation into in-
fant formula supports a sufficient supply of essential 
amino acids including Trp in FF infants  [26, 27] . Studies 
on increased ALAB contents in formulae have shown 
11–57 kcal/day lower energy intakes and 0.9–1.9 g/day 
higher weight gains  [9, 13, 14] . Combination of these 
factors increases the EE for weight by about 0.56–
0.78 g/100 kcal. Dietary ALAB is associated with higher 
plasma Trp concentrations  [9, 14] . Since Trp is a precur-
sor of serotonin and melatonin, this might affect appe-
tite regulation, satiety, and the sleep-wake rhythm  [28] . 
If ALAB-rich formulae induce greater satiety, a lower 
energy intake may result. Further indication of the im-
portance of Trp is obtained from studies which investi-
gated the addition of free Trp to infant formulae. In the 
study of Hanning et al.  [2] , a high Trp content without 
an increase in the whey-to-casein ratio or the ALAB 
content resulted in a 63 kcal/day lower energy intake 
compared to the control group. Trp is more quickly ab-
sorbed in its free form than as protein-bound amino 
acid and may reach tissues such as the brain or liver 
more rapidly  [25] . The resulting increase in the ratio of 
Trp to the other large neutral amino acids could lead to 
greater satiety and less formula intake  [2] .
 Consistent results indicate a strong relationship be-
tween a higher whey-to-casein ratio and a higher EE  [12, 
13, 15, 17] . Whey-dominant formulae have a whey-to-
casein ratio (60: 40) similar to that of human milk in ear-
ly lactation  [29] . Whey has a slightly higher protein 
quality (protein digestibility-corrected amino acid 
score) than casein and is more easily digested by the gas-
trointestinal system  [30] . Similar effects of higher whey-
to-casein ratios on EE are observed with greater con-
tents of intact whey  [12, 13, 15] or fully hydrolyzed whey 
 [17] . 
 Although the increased EE of infant formulae may be 
considered beneficial, infantile growth should not exceed 
the growth of BF infants by feeding large volumes of en-
ergetically highly efficient formulae. High growth veloc-
ities in early infancy have been related to higher adipos-
ity and type 2 diabetes risks in later life  [4, 5, 8, 31] . Thus, 
a potential benefit for infants is derived from consuming 
smaller amounts of high-quality formula, while achiev-
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bolic burden. With respect to protein intake, this enables 
a reduction of the renal load via a lower nitrogen intake 
and a consequent reduction of the excretion of excess ni-
trogen  [32] . 
 This review and its conclusion are limited by the qual-
ity of the trials included. One of 14 trials was not a ran-
domized controlled trial  [10] , and 2 of 13 studies had a 
very small sample size  [10, 11] . In most studies, more 
than one macronutrient-related factor differed between 
the compared formulae. Furthermore, the included stud-
ies were heterogeneous, which precluded a meta-analy-
sis. Thus, conclusions on specific factors are limited, and 
this review may rather be considered hypotheses gener-
ating. Evaluation of the EE of a study is difficult when 
there are parallel changes in the quality and content of a 
nutrient. This literature review of 14 intervention trials 
indicates that also minor changes in the macronutrient 
quality or source of an infant formula have an impact on 
the EE for growth.
 We conclude that there are indications for EE-in-
creasing effects of an increased whey-to-casein ratio, a 
higher ALAB content, a higher Trp content, and im-
proved fat absorption in infant formulae, while the ef-
fects of the carbohydrate source are small. These findings 
may contribute to explaining the differences in growth 
and metabolism between BF and FF infants and may be 
useful for developing further strategies aimed at reduc-
ing the remaining gap in metabolic processes between FF 
and BF infants. 
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